AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Contingent Consideration Liability by Year
Contingent Consideration Liability — Noncurrent Portion [year-end] ($M) ($M)
AbbVie Contingent Consideration Liability: $21,919M in FY2025, up 14.9% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-K Note 10 Financial Instruments & Fair Value.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Contingent Consideration Liability — Noncurrent Portion [year-end] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21,919 | +14.9% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 19,077 | +6.3% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 17,938 | +20.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 14,915 | +9.4% | Form 10-K (filed 2024-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 13,638 | +11.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2020 | Dec 31, 2020 | 12,289 | +70.7% | Form 10-K (filed 2022-02-18) ↗ |
| FY2019 | Dec 31, 2019 | 7,201 | +67.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 4,306 | +0.9% | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 4,266 | +8.2% | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 3,941 | – | Form 10-K (filed 2018-02-16) ↗ |
| FY2015 | Dec 31, 2015 | 0 | – | Form 10-K (filed 2017-02-17) ↗ |
Cite this data
StockData. (2026). AbbVie Contingent Consideration Liability ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cc-liab-nc
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.